Navigation Links
Blackrock Microsystems’ BCI Technology Selected for Collaboration with Republic of Poland

Last week, Blackrock Microsystems, LLC, Neuro Device Group SA, and a group of doctors, scientists and engineers from the Medical University of Warsaw, met at the Presidential Palace of the Republic of Poland to present the results of their work to-date in creating a neuroprosthetic system as part of an initiative called "Startups in the Palace – Cooperation," aimed at supporting the development of Polish startups and future technologies.

The goal of the working group is to improve neuroscience research, support the work of local clinical institutions, and to drive innovation in the region leveraging Blackrock Microsystems’ brain computer interface (BCI) technology, and expertise in enabling successful human research trials. Blackrock Microsystems’ Utah Array and BCI system are the only devices of their kind that have 510k clearance for human use by the FDA. Both have become a gold standard for human-subject studies in both brain computer interface (BCI) and peripheral nerve implantations.

“Poland is well positioned in the field of software development and AI and we’re looking at applications that can benefit our people most, particularly patients with damage to the neurosystem,” said Marta Gajecka, Advisor to the President of the Republic of Poland. “By bringing in the gold standard of BCI, and developing cross-disciplinary partnerships with the best institutions across Poland, we are ensuring that we are well-positioned to pioneer neuroscience research technologies.”

The clinical team participating in the collaboration is led by Dr. Przemyslaw Kunert, Deputy Chair of Neurosurgery at The Medical University of Warsaw, the largest medical school in Poland. Its Neurosurgery Clinic was the first hospital department in Poland to treat neurosurgical diseases and serves as a Polish referential center for diagnosis and treatment of neuromuscular diseases. As an active clinical trial site, the multidisciplinary team is involved in both local and international research programs.

“We are proud to expand our global partnerships to include leading research institutes and startups in Poland, and to support what we hope will result in the first BCI pioneer in Eastern Europe,” said Blackrock CEO, Marcus Gerhardt. “We are on the frontier of developing novel approaches to address a number of disorders of the nervous system, and this cross-disciplinary initiative will continue to expand the opportunities for BCI technologies. We applaud the Republic of Poland for seeing the need for investment in this critical research.”

NeuroDevice Group, SA is a neuroscience technology company led by Pawel Soluch and based in Warsaw. It is one of the startups that have been selected by the Chancellery of the President to participate in the initiative. The meeting at the Presidential Palace initiated the next phase of work on the neuroprothetics technologies created by NeuroDevice, and enabled by Blackrock Microsystems’ Utah Array and BCI system.

For more information about Blackrock Microsystems and the Utah Array, visit


About Blackrock Microsystems
Blackrock Microsystems, based in Salt Lake City, Utah, was founded in 2008 and is the world’s leading provider of technology in the neuroscience, neural engineering, and neural prosthetics space. The company’s technology is at the core of worldwide innovations in Brain-Machine Interfaces (BMI/BCI), implantable bionic technologies and epilepsy diagnostics. Most impactful implantations of the Utah Array have been in some tetraplegic individuals from University of Pittsburgh’s Nathan Copeland, who controlled a prosthetic arm to fist bump US President Barack Obama in 2016; Ohio State University’s Ian Burkhart who is learning to control an automobile, and CalTech’s Nancy Smith who is learning to play a virtual piano. Seemingly easy tasks, all have used the Utah Array to translate their thoughts into action to restore function.

Read the full story at

Source: PRWeb
Copyright©2019 Vocus, Inc.
All rights reserved

Related biology news :

1. Cutting Edge Spine Announces FDA 510(K) Clearance of its EVOL-SI Joint Fusion System; Bringing Novel Super Hydrophilic Nano-technology to the Sacral-iliac Fixation Market
2. Developments in Microbial Technology – Pioneers With Proven Success on Advancements Series
3. Bioscience for a Better Tomorrow – Exploring Recent Breakthroughs in Medical Technology on Advancements TV Series
4. SD Mines Researcher Develops New Technology to Detect Bone Loss in Astronauts and Potentially Screen for Cancer in General Population
5. KMK Consulting, Inc. Expands Presence in Boston to Help Biotechnology Companies from Pre-Launch to Commercialization
6. Asymmetrex Approved to Conduct an ASTM Interlaboratory Evaluation of Its AlphaSTEM Test™ Technology as a Standard for Counting Therapeutic Adult Tissue Stem Cells
7. Asymmetrex Presents Proposal for ASTM Interlaboratory Evaluation of AlphaSTEM Test™ Technology Towards Establishing A Standard for Counting Therapeutic Stem Cells
8. Modality Solutions’ President Gary Hutchinson Accepted into Forbes Technology Council
9. Managing a Successful Direct-to-Patient Trial Using Interactive Response Technology, Upcoming Webinar Hosted by Xtalks
10. Top 50 Healthcare Technology CEOs of 2019
11. Peer-Reviewed Paper in Frontiers in Bioengineering and Biotechnology Reveals that uBiome Has the Largest Patent Portfolio in the Microbiome Space
Post Your Comments:
(Date:10/3/2019)... ... ... Personalized Stem Cells, Inc (“PSC”), a human adipose-derived stem cell company, ... stem cell treatment of knee osteoarthritis . The successful enrollment comes only a little ... Biopharma. , PSC CEO, Michael Dale, stated, “We are proud that as we celebrate ...
(Date:9/30/2019)... ... September 30, 2019 , ... ... mesenchymal stem/stromal cell (hMSC) biomanufacturing systems, today announced it has received patent ... product formats (patent number AU 2015259373). This new patent adds intellectual property ...
(Date:9/25/2019)... ... ... Deep Science Ventures (DSV), a new paradigm for applied science, today ... research. , Deep Science Ventures was founded to create a better method for launching ... start, both at the industry and biological level. , Through their partnership with ...
Breaking Biology News(10 mins):
(Date:10/10/2019)... VEGAS (PRWEB) , ... October 10, 2019 , ... R3 ... courses. The next course is October 18-19th, 2019 in Las Vegas with spots still ... exosomes. He completed training at several Ivy League universities including Cornell, Harvard and Dartmouth. ...
(Date:10/8/2019)... (PRWEB) , ... October 07, 2019 , ... ... of low level laser therapy technology (“3LT®”), today announces that the U.S. Food ... its EVRL low level laser for the temporary relief of chronic neck and ...
(Date:10/3/2019)... (PRWEB) , ... October 01, 2019 , ... Cheyenne is ... program. Mimi, Cheyenne’s owner, owns and operates Rebel’s Run , which offers ... a favorite amongst students and trail riding guests. Mimi describes her as her ...
(Date:10/3/2019)... ... October 02, 2019 , ... eKare’s inSight® digital 3D ... Health Accelerator run by the East Midlands Academic Health Science Network (EMAHSN), the innovation ... technology in NHS by providing support to develop and deploy solutions to the most ...
Breaking Biology Technology: